Fidelity Management and Research co-led a round that more than doubled the Amazon, Comcast and American Express-backed grocery delivery service's valuation to $39bn.

Atlantia, Continental, Intel Capital, Klocke, NTTVC and Tokyo Century were among the investors in a round that took the air taxi developer’s overall funding to near $390m.

Xenotransplantation technology developer eGenesis took its total funding to $263m in a series C round backed by Bayer and Fresenius Medical Care.

GV returned for a series C round that helped the precision cancer medicine developer increase its overall funding to over $180m.

Osage University Partners has thrown its weight behind a series A2 round for Artizan, which is advancing work undertaken at Yale University.

Biohaven Therapeutics co-led Artizan Biosciences' latest round as part of an option and licensing agreement focusing on its inflammatory bowel disease drug candidates.

Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.

The Vertex Pharmaceuticals-backed genomic analytics platform developer has now raised approximately $88m in funding altogether.

An unnamed casino operator invested in the sports and esports betting platform developer in around that will support international expansion.

The low-code app app development software provider's eight-figure round included BAI and SIG Asia.